AlexanderSolkyMD

Oncology • Rochester, NY

President, Interlakes Oncology/Hematology PC

Join to view full profile

Dr. Solky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Solky's full profile

Already have an account?

Office
Interlakes Oncology Hematology PC
211 White Spruce BLVD
Rochester, NY 14623
Phone+1 585-475-8700

Fax+1 585-475-9411

Education & Training

University of RochesterFellowship, Hematology and Medical Oncology, 1999 - 2001
University of RochesterResidency, Internal Medicine, 1996 - 1999
University of Rochester School of Medicine and DentistryClass of 1996

Certifications & Licensure

NY State Medical License 1999 - 2022

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Publications & Presentations

PubMed

524 citations
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Harold J. Burstein, Sarah Temin, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson
Journal of Clinical Oncology. 2014-07-20
192 citations
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian ...
Harold J. Burstein, Christina Lacchetti, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson
Journal of Clinical Oncology. 2016-09-27
354 citations
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
Harold J. Burstein, Christina Lacchetti, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson
Journal of Clinical Oncology. 2019-02-10

Press Mentions

Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateFebruary 10th, 2020